Manufacturing

BFS_logo_RGB_800px


 

Curida is a member of The Pharmaceutical Blow-Fill-Seal International Operators Association (BFS IOA), an international industry association for pharmaceutical and associated companies, since its first year of establishment, 1988. http://www.bfsioa.org


 
Curida’s holistic business approach to consider the unity of product content and delivery device in the development and in the further manufacturing process puts them into a leading position in the pharmaceutical industry. I am delighted to cooperate with such well-focused company and to contribute actively to the business success of Curida.
- Dr. René Bommer

Pharmaceutical Manufacturing since 1974

Curida’s core competency is in state-of-the-art manufacturing of sterile liquid pharmaceuticals based on
unit-dose Blow-Fill-Seal (BFS) technology, ensuring a high quality, fast and robust process with minimal human intervention. We are also experienced in the manufacturing of nasal spray and bottled products. With our specialization in liquid manufacturing and expert know-how, we can provide investigational medicinal products (IMPs) for clinical studies. Curida’s facilties are suitable and fully equipped to handle controlled drugs.

 
In addition to full-scale manufacturing, we offer small-scale production for samples and stability testing. Contact us for further details.


Certifications

Certificate of compliance with current Good Manufacturing Practices (cGMP) for medicinal products for human

 

Certificate of compliance with current Good Manufacturing Practices (cGMP) for investigational medicinal products

 

Certificate of compliance with ISO 13485:2003


 

Blow-Fill-Seal Technology, manufacturing since 1982

  • Capacity: 165 million units
  • 5 Blow-Fill-Seal (bottlepack) machines
  • Unit-dose content: 0.1–0.4 mL and 5–30 mL
  • Sterile/non sterile
  • Aseptic production

 

Nasal Spray, manufacturing since 1989

  • Capacity: 20 million units divided on two production lines
  • Glass/plastic vials with dosing pumps
  • Preserved and preservative free
  • Non-aseptic
  • Filling volume: 10–30 mL
  • Closing systems for crimp, rolling and snap-on devices
  • Secondary packaging: boxes with inserts
  • Filling and assembling equipment for single dose nasal spray
    • Filling volume 0.1–0.2 mL

 

Bottles, manufacturing since 1974

  • Capacity: Scalable production to 12 milllions units
  • Bottle volumes: 100–500 mL
  • Non-sterile
  • Solutions, emulsions and suspensions
  • Experience with products containing ethanol, up to 32 %
  • Experience with light sensitive products
  • Pilot equipment for tech transfer and clinical batches